Physician profile
Suzanne Palmieri
NPI 1184691842
$10,052.71
in general payments reported to CMS, 2019-2025
41 companies · $1,909 in 2025
The $1,909 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $412 · 2021: $1,334 · 2022: $1,871 · 2023: $2,357 · 2024: $2,170 · 2025: $1,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,411 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,411.38 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,787.53 | 2021-2025 | |
| Novo Nordisk INC | $1,732.57 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $1,043.45 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $869.83 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $692.00 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $460.91 | 2021-2025 | Jardiance, Ofev |
| Astrazeneca Pharmaceuticals LP | $425.78 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $410.32 | 2022-2025 | Evenity, Prolia, Otezla |
| Astellas Pharma US INC | $229.52 | 2020-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $219.50 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $177.11 | 2022 | |
| Abbott Laboratories | $174.92 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Biohaven Pharmaceuticals, INC. | $161.37 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $150.49 | 2020-2025 | Steglatro, Belsomra, Gardasil 9 |
| Idorsia Pharmaceuticals US INC | $144.45 | 2022-2023 | Quviviq |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Palmieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.